{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:36:30Z","timestamp":1790314590190,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T00:00:00Z","timestamp":1298505600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00404-011-1864-3","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T07:20:01Z","timestamp":1298445601000},"page":"1501-1507","source":"Crossref","is-referenced-by-count":11,"title":["Usefulness of computed tomography in predicting cytoreductive surgical outcomes for ovarian cancer"],"prefix":"10.1007","volume":"284","author":[{"given":"Kazuko","family":"Fujwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Miyatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Muraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruyasu","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,24]]},"reference":[{"key":"1864_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","volume":"334","author":"WP McGuire","year":"1996","unstructured":"McGuire WP, Hoskins WJ, Brady MF et al (1996) Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334:1\u20136","journal-title":"N Engl J Med"},{"key":"1864_CR2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jnci\/92.9.699","volume":"92","author":"MJ Piccart","year":"2000","unstructured":"Piccart MJ, Bertelsen K, James K et al (2000) Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst 92:699\u2013708","journal-title":"J Natl Cancer Inst"},{"key":"1864_CR3","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248\u20131259","journal-title":"J Clin Oncol"},{"key":"1864_CR4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2006.11.025","volume":"105","author":"JY Hou","year":"2007","unstructured":"Hou JY, Kelly MG, Yu H, McAlpine JN, Azodi M, Rutherford TJ, Schwartz PE (2007) Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease. Gynecol Oncol 105:211\u2013217","journal-title":"Gynecol Oncol"},{"key":"1864_CR5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","volume":"363","author":"I Vergote","year":"2010","unstructured":"Vergote I, Trope CG, Amant F et al (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 363:943\u2013953","journal-title":"N Engl J Med"},{"key":"1864_CR6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1098-2388(200007\/08)19:1<42::AID-SSU7>3.0.CO;2-M","volume":"19","author":"J Dauplat","year":"2000","unstructured":"Dauplat J, Le Bouedec G, Pomel C, Scherer C (2000) Cytoreductive surgery for advanced stages of ovarian cancer. Semin Surg Oncol 19:42\u201348","journal-title":"Semin Surg Oncol"},{"key":"1864_CR7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ygyno.2008.12.027","volume":"113","author":"T Onda","year":"2009","unstructured":"Onda T, Kobayashi H, Nakanishi T et al (2009) Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III\/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206. Gynecol Oncol 113:57\u201362","journal-title":"Gynecol Oncol"},{"key":"1864_CR8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1200\/JCO.1993.11.1.166","volume":"11","author":"BE Nelson","year":"1993","unstructured":"Nelson BE, Rosenfield AT, Schwartz PE (1993) Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol 11:166\u2013172","journal-title":"J Clin Oncol"},{"key":"1864_CR9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/cncr.20376","volume":"101","author":"SC Dowdy","year":"2004","unstructured":"Dowdy SC, Mullany SA, Brandt KR, Huppert BJ, Cliby WA (2004) The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer 101:346\u2013352","journal-title":"Cancer"},{"key":"1864_CR10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1200\/JCO.2006.07.7800","volume":"25","author":"AE Axtell","year":"2007","unstructured":"Axtell AE, Lee MH, Bristow RE et al (2007) Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol 25:384\u2013389","journal-title":"J Clin Oncol"},{"key":"1864_CR11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ajog.2005.03.058","volume":"193","author":"EN Everett","year":"2005","unstructured":"Everett EN, Heuser CC, Pastore LM, Anderson WA, Rice LW, Irvin WP, Taylor PT (2005) Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancer. Am J Obstet Gynecol 193:568\u2013574 discussion 574\u2013566","journal-title":"Am J Obstet Gynecol"},{"key":"1864_CR12","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A","volume":"89","author":"RE Bristow","year":"2000","unstructured":"Bristow RE, Duska LR, Lambrou NC, Fishman EK, O\u2019Neill MJ, Trimble EL, Montz FJ (2000) A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89:1532\u20131540","journal-title":"Cancer"},{"key":"1864_CR13","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ejso.2009.03.002","volume":"35","author":"O Gemer","year":"2009","unstructured":"Gemer O, Gdalevich M, Ravid M et al (2009) A multicenter validation of computerized tomography models as predictors of non-optimal primary cytoreduction of advanced epithelial ovarian cancer. Eur J Surg Oncol 35:1109\u20131112","journal-title":"Eur J Surg Oncol"},{"key":"1864_CR14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1525-1438.2007.01114.x","volume":"18","author":"AE Bland","year":"2008","unstructured":"Bland AE, Everett EN, Pastore LM, Andersen WA, Taylor PT Jr (2008) Predictors of suboptimal surgical cytoreduction in women with advanced epithelial ovarian cancer treated with initial chemotherapy. Int J Gynecol Cancer 18:629\u2013636","journal-title":"Int J Gynecol Cancer"},{"key":"1864_CR15","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.bjc.6605292","volume":"101","author":"G Ferrandina","year":"2009","unstructured":"Ferrandina G, Sallustio G, Fagotti A et al (2009) Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial. Br J Cancer 101:1066\u20131073","journal-title":"Br J Cancer"},{"key":"1864_CR16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/gyno.2000.5749","volume":"77","author":"DS Chi","year":"2000","unstructured":"Chi DS, Venkatraman ES, Masson V, Hoskins WJ (2000) The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. Gynecol Oncol 77:227\u2013231","journal-title":"Gynecol Oncol"},{"key":"1864_CR17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1525-1438.2003.13019.x","volume":"13","author":"S Memarzadeh","year":"2003","unstructured":"Memarzadeh S, Lee SB, Berek JS, Farias-Eisner R (2003) CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer. Int J Gynecol Cancer 13:120\u2013124","journal-title":"Int J Gynecol Cancer"},{"key":"1864_CR18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2007.11.004","volume":"108","author":"R Salani","year":"2008","unstructured":"Salani R, Axtell A, Gerardi M, Holschneider C, Bristow RE (2008) Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer. Gynecol Oncol 108:271\u2013275","journal-title":"Gynecol Oncol"},{"key":"1864_CR19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L et al (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34\u201343","journal-title":"N Engl J Med"},{"key":"1864_CR20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jgyn.2009.12.007","volume":"39","author":"JM Classe","year":"2010","unstructured":"Classe JM, Muller M, Frenel JS, Berton Rigaud D, Ferron G, Jaffre I, Gladieff L (2010) Intraperitoneal chemotherapy in the treatment of advanced ovarian cancer. J Gynecol Obstet Biol Reprod Paris 39:183\u2013190","journal-title":"J Gynecol Obstet Biol Reprod Paris"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-011-1864-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-011-1864-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-011-1864-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T19:29:45Z","timestamp":1560022185000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-011-1864-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,24]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1864"],"URL":"https:\/\/doi.org\/10.1007\/s00404-011-1864-3","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,24]]}}}